FDA Grants Accelerated Approval for New Multiple Myeloma Treatment
New Multiple Myeloma Treatment Receives Accelerated Approval from FDA The FDA has granted accelerated approval to Lynozyfic (linvoseltamab-gcpt), a groundbreaking bispecific antibody treatment for patients with relapsed or refractory multiple…
